A Review and Comparison of Frameworks used in Behavioral Intervention Development Research - Shared screen with speaker view
Also, please send comments or questions to us via the chat function
It seems that she is moving forward, but slides are not
Thanks to you both for letting us know..
Can/how often are Stage 1 & Stage 2 research combined?
The Onken et al Stage Model is very parallel to the translational research model used in CTSA's, in cancer research (for many years - Greenwald et al.), and so on. Do you (or does Lisa et al.) see it as the behavioral science/change adaptation of those models?
Janet Prvu Bettger
Thanks for joining us Dr. Onken
So this target is then a mediator on the causal pathway?
Can you explain how you differentiate "theory" vs "model"? What makes something a theory vs model - since the terms are often used interchangeably?
Do we know what is causing that sound?
Lavanya Vasudevan, Ph.D.
When we are considering these different frameworks, on what factors should we base the selection of one framework over another?
Do intervention development models address the idea that people respond differently to interventions (i.e. heterogenous treatment effects)? If not, do you have any suggestions for how to take that into consideration when we develop and test interventions?
Interesting question, Megan. I would think heterogeneity of treatment effects is better defined in the analytic model (vs. intervention development models). Thinking sub-group analyses to test impactful mediating factors etc., but this predicated on a large and diverse patient sample by which to appropriately look at this heterogeneity across groups and clinical characteristics. Would be curious what you and others think.
That is my sense, Katherine, and what I messaged to MSB. Speaks to cultural adaptation and tailoring
That makes sense and I agree with the need for large and diverse samples and then plan to do sub-group analyses. I wonder whether some preliminary work during early stages can start to get at this because sometimes we don't know/can't anticipate which characteristics will affect treatment. This has been a great presentation--thank you!
This has been a great talk! Thanks for the opportunity to grow and learn.
Will the ppt file be shared to the attendees?
Jessie Byrd, M.Ed.
Slides and recording will be shared with everyone. Thanks for asking
Great. Thank you.
Thank you so much! this was fantastic
Thank you! This was outstanding.
Dr Charles Wood
Are there any broad differences in behavior change when the behavior hasn't begun yet (i.e. preventing behaviors from developing)? In pediatrics, we are often working on avoiding developing detrimental feeding behaviors. Are there specific models that address prevention?
Thank you for the presentation.
Thank you Dr. Czajkowksi!
Jennifer Plumb Vilardaga
This was fantastic, thank you thank you!